News

Velocity and Stitch expand global partnership to advance evidence-driven patient engagement

Full network expansion to all studies at 70+ global locations follows a year-long collaboration that improved show-rates by up to 9 percentage points across nearly 100k scheduled screenings.  Today, we are excited to announce that Velocity Clinical Research, the world’s largest organization of fully owned and integrated clinical research sites, is deepening its aligned partnership … Read more

The Habit That’s Quietly Running Your Trial

By Nick Spittal, Chief Operations Officer, Velocity Clinical Research  Most sponsors and CROs talk about slow sites, hard-to-find patients, and protocol complexity putting their studies at risk. Those issues are all real, and they frequently share the same underlying cause: the disparate operating model used across individual study sites. In my experience, study risk often … Read more

Velocity Establishes a New Industry Benchmark, Entering 97% of Patient Data Within 24 Hours of Collection

Velocity Clinical Research, the world’s largest integrated global site network, today announced that its centralized Electronic Data Capture (EDC) model is now entering 97% of clinical trial data within one business day of patient visits — two to four days faster than the industry average of five days reported in independent benchmarking studies. Additionally, data … Read more

The Business Intelligence Paradox: More Data, Better Systems, Similar Decisions

By Tyler Beasley, Executive Director, Business Intelligence Over the last several years, clinical research organizations have invested heavily in business intelligence infrastructure. Enterprise reporting has replaced manually maintained spreadsheets and datasets. Data warehouses have helped to partially bridge the gap with previously disconnected systems. ​​Dashboards now deliver visibility into nearly every aspect of study execution, … Read more

Velocity Delivers Vaccine Trial Enrollment at Scale — On Both Sides of the Atlantic

When a large-scale vaccine trial needed to move fast, Velocity delivered — not once, but twice, across two continents. In the United States, Velocity was the sole site network selected to enroll participants for the trial. Across just 10 sites, the team enrolled 1,000 participants in 3.5 weeks. That’s the kind of speed that only … Read more

Better Matches, Faster: How Agentic AI Is Changing Clinical Trial Feasibility

By Sweta Pittala, VP, Technology Portfolio Management At a Glance Responding to Requests for Proposal (RFPs) is one of the most labor-intensive processes in clinical trial operations. Velocity’s Feasibility Agent automates and augments that process, drawing on years of data on site performance from 70+ global sites, PI experience, and local recruitment trends to produce … Read more

Kris Kowdley, MD Featured in Ipsen’s ELSPIRE Trial Announcement

Congratulations to Ipsen on positive Phase IIIb results from the ELSPIRE trial evaluating IQIRVO® (elafibranor) in patients with Primary Biliary Cholangitis (PBC). The trial met its primary endpoint with statistical significance, with 85% of patients treated with IQIRVO achieving ALP normalization versus 23% on placebo — a result with meaningful implications for how the field … Read more

The New AI Baseline… and How Sponsors Build an Advantage

By Nick Spittal, Chief Operations Officer, Velocity Clinical Research How many times have you heard the term AI this week? Sponsors are investing in it, CROs are building for it, and tech vendors are popping up left, right, and center to sell it. Sites are fully in the crosshairs, with hundreds of hours of procurement … Read more

What It Actually Means to Be a Partner in Clinical Research

By Andrew Reina, Chief Revenue Officer I spent the better part of two decades on the CRO side of clinical research, which gives you a particular vantage point. You see how sponsors evaluate site networks, what they ask for, and (more tellingly) what they don’t. Historically, this is a transactional relationship; a site’s job is … Read more